Tucson, Arizona, United States Research Corporation Technologies is the famous Corporate Investor, which was founded in 1987. The main office of represented Corporate Investor is situated in the Tucson. The venture was found in North America in United States.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Research Corporation Technologies, startups are often financed by California Technology Ventures, Ben Franklin Technology Partners of Southeastern Pennsylvania, William Harris Investors. The meaningful sponsors for the fund in investment in the same round are California Technology Ventures, BroadOak Capital Partners, Aphelion Capital. In the next rounds fund is usually obtained by Aphelion Capital, Themelios Ventures, Stanmore Medical Investments.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Therapeutics, Pharmaceutical. Among the various public portfolio startups of the fund, we may underline Dispersol Technologies, Providence Medical Technology, Cylene Pharmaceuticals
The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2016. The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2015. Speaking about the real fund results, this Corporate Investor is 27 percentage points more often commits exit comparing to other organizations.
Funds with similar focus
| Fund Name | Location |
| 7cool | China, Jiangsu, Wuxi Shi |
| Athyrium Capital Management, LP | New York, New York, United States |
| Developing World Markets | Connecticut, Stamford, United States |
| Hanse Ventures | Germany, Hamburg |
| Henglu Assets | China, Shanghai |
| NXT | - |
| Shonai Bank | Japan, Tsuruoka, Yamagata Prefecture |
| Sirius Angel Fund | Central, Central Region, Singapore |
| Y Experiment | Greater Poland Voivodeship, Poland, Poznań |
| Yorkville Advisors | Mountainside, New Jersey, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Pheon Therapeutics | $120M | 21 May 2024 | London, England, United Kingdom | ||
S2 Genomics | $16M | 23 Jan 2024 | California, United States | ||
iotaMotion | $12M | 26 Jul 2023 | Iowa, United States | ||
Pheon Therapeutics | $68M | 28 Sep 2022 | London, England, United Kingdom | ||
Halo Labs | $7M | 11 Jul 2022 | Philadelphia, Pennsylvania, United States | ||
seqWell | $7M | 29 Mar 2022 | Beverly, Massachusetts, United States | ||
Pheon Therapeutics | 01 Jan 2022 | London, England, United Kingdom | |||
Q'Apel Medical | $22M | 11 Feb 2021 | Fremont, California, United States | ||
Halo Labs | $12M | 06 Apr 2020 | Philadelphia, Pennsylvania, United States |
– Q’Apel Medical Raises $22M in Funding.
– The round included River Cities Capital, Soleus Capital, and incumbent investor Research Corporation Technologies (RCT).
– The new investment will be used to increase manufacturing capacity, expand product portfolio and add additional head count.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Pheon Therapeutics | $120M | 21 May 2024 | London, England, United Kingdom | ||
S2 Genomics | $16M | 23 Jan 2024 | California, United States | ||
iotaMotion | $12M | 26 Jul 2023 | Iowa, United States | ||
Pheon Therapeutics | $68M | 28 Sep 2022 | London, England, United Kingdom | ||
Halo Labs | $7M | 11 Jul 2022 | Philadelphia, Pennsylvania, United States | ||
seqWell | $7M | 29 Mar 2022 | Beverly, Massachusetts, United States | ||
Pheon Therapeutics | 01 Jan 2022 | London, England, United Kingdom | |||
Q'Apel Medical | $22M | 11 Feb 2021 | Fremont, California, United States | ||
Halo Labs | $12M | 06 Apr 2020 | Philadelphia, Pennsylvania, United States |
